What We Do
FRS is a class action recovery and cost savings firm that specializes in, among other services, class action settlement claims recovery. FRS manages your class action claims, from tracking litigations to settlement distributions.
Why Companies Choose FRS
FRS has spent the last 16 years building the best team in the industry for class action claims management. We have recovered, on our clients’ behalf, over $200M from class action settlements and other recovery opportunities.
FRS is entrusted by over 44,000 clients every day, including many Fortune 500 companies.
Claims Management Services
Industry Leading Research
Providing effective notice when
FRS learns of settlements that
may be valuable.
Claims Management
Preparing, assembling and submitting claims, and managing them.
Enhancing Claims
Enhancing the likelihood that
eligible business units are included
in the claim process.
Consistent Updates
Providing regular updates on the
recovery process and related
developments.
Innovate & Negotiate
Developing innovative
alternatives when required
documents are not available.
Professional Advice
Providing advice on what, if any,
documents need to be collected.
Auditing
Auditing clients’ recoveries to
assure that their checks have not
been under calculated.
Contact us to learn more about FRS's services.
Full Research Team
The FRS team has developed innovative solutions to data requirements to significantly reduce the amount of time required by your in-house team. We keep your sensitive data private, and minimize the hassle of searching for old or destroyed documentation.
Success Stories
FRS’s client, a large “Fortune” company, estimated that, in the Vitamins settlement, FRS’s successful advocacy for alternative documentation and estimation saved approximately 150 hours of in-house work and obtained a recovery for the vast majority of its purchases.
FRS, on behalf of four of our healthcare system clients in the Blood Reagents settlement, received defendant purchase data that totaled approximately $985,000. FRS worked with our clients to increase those purchases to approximately $2.6 million, or by more than 2.5 times, which increased their recoveries by over $425,000.
FRS’s client, a world leader in the distribution of chemicals and related products and services, had incorrectly determined that it was not eligible to recover from the settlement of the Vitamin C Antitrust Litigation. FRS established that over $19,000,000 of their purchases were eligible, which resulted in a recovery of over $1.4 million.
Current Class Actions
Auto Parts Indirect Purchaser 2
Auto Parts Indirect Purchaser 2
Fund (US): $3,152,000
Individuals or entities who or which indirectly purchased in one of the Eligible Jurisdictions, from January 1, 2002 to the present, Automotive Parts that were manufactured by one or more of the Defen...
Read moreFiling Deadline: 2023-01-07
Auto Parts Canada 2
Auto Parts Canada 2
Fund (US): $78,370,964
All individuals, dealerships or entities who directly or indirectly purchased or leased a new or used vehicle in Canada, purchased a new or used vehicle for import into Canada or purchased an automoti...
Read moreFiling Deadline: 2023-10-30
Bank Bill Swap Rates (Australian BBSW)
Bank Bill Swap Rates (Australian BBSW)
Fund (US): $185,875,000
All persons and entities (excluding the United States Government) who or which, from January 1, 2003 through August 16, 2016, purchased, sold, held, traded, or otherwise had any interest in Bank Bill ...
Read moreFiling Deadline: 2023-01-16
Beef Commercial and Institutional Indirect
Beef Commercial and Institutional Indirect
Fund (US): $25,000,000
All persons and entities who, from January 1, 2015, to May 25, 2023, indirectly purchased for business use in commercial food preparation in the United States, from any of the Defendants or their resp...
Read moreApple App Developer
Apple App Developer
Fund (US): $100,000,000
Eligible class members include all former and current “U.S. Developers” (defined below) that developed any Apple Inc. (hereafter, “Apple” or “Defendant”) iOS application or in-app product ...
Read moreFiling Deadline: 2022-05-20
Actos TPP (Pioglitazone)
Actos TPP (Pioglitazone)
All entities that, for consumption by their members, insureds, or beneficiaries, paid and/or provided reimbursement for some or all of the purchase price of Actos or generic pioglitazone in the Eligib...
Read moreActhar TPP
Acthar TPP
The proposed class includes all third-party payors in the United States and its territories who purchased and paid for H.P. Acthar Gel indirectly from Defendants for their own use and not for resale f...
Read moreAffordable Care Act Transitional Reinsurance Program
Affordable Care Act Transitional Reinsurance Program
The proposed class includes all self-insured employee health and welfare benefit plans with assets held pursuant to a trust agreement that were required to make the Transitional Reinsurance Contributi...
Read more